Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372255
Status:
COMPLETED
Last Update Posted:
2019-05-06
First Post:
2006-09-05
Brief Title:
Study on the Immunogenicity and Tolerability of Influsplit SSW 20052006 in Children Aged 6 - 13 Years
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
An Open Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW 20052006 in Children Aged 6 - 13 Years
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will evaluate the immune response and the tolerability of the influenza vaccine administered in children aged 6-13 years old
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-004517-14 | EUDRACT_NUMBER | None | None |